PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...

PCI Pharma Services, a Philadelphia-based biotherapy-focused contract development and manufacturing organization, has secured an investment co-led by Bain Capital and existing backer Kohlberg.

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

Kohlberg Ventures LLC‘s victory over a challenge from the founder of Akademos Inc. to the education technology company’s ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

MarketCast promoted Amy Fenton from co-president to CEO of the market research and analytics firm. Fenton, who joined the ...

MarketCast, a leading technology and data-enabled market research and analytics firm, announced today current Co-President ...

Fintel reports that on July 14, 2025, Jefferies initiated coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a Buy ...

Fintel reports that on July 14, 2025, Baird downgraded their outlook for Henry Schein (NasdaqGS:HSIC) from Outperform to Neutral. Analyst Price Forecast Suggests 5.68% Upside As of June 20, 2025, the ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.

A growing list of DJs have pulled out of performing at a popular party due to private equity firm KKR’s links to Israel ...